Login / Signup

SABCS 2017: update on chemotherapy, targeted therapy, and immunotherapy.

Rupert BartschElisabeth Bergen
Published in: Memo (2018)
In the areas of chemotherapy, targeted therapy and immunotherapy, several interesting and clinically relevant data were presented at the 2017 San Antonio Breast Cancer Symposium (SABCS). This short review focuses on dose-dense and/or sequential administration of adjuvant chemotherapy, provides an update on targeted therapies for HER2-positive and triple-negative breast cancer and summarizes new results in the field of immunotherapy.
Keyphrases
  • locally advanced
  • electronic health record
  • radiation therapy
  • chemotherapy induced
  • rectal cancer
  • machine learning
  • young adults
  • data analysis